Table 2.
Timing and length of Treat All implementation at IeDEA sites
| Timing of Treat All implementation (sites with known year of implementation) | Time (in months) from national adoption to site implementationa in countries where Treat All adopted nationally | Length of implementation (in months) among sites in countries where Treat All not yet adopted nationally | ||||
|---|---|---|---|---|---|---|
| N | Median [IQR] | N | Median [IQR] | N | Median [IQR] | |
| All sites | 178 | 2016 [2015 to 2016] | 138 | 1 [−1, 4] | 14 | 7.4 [5.6, 12.7] |
| IeDEA region | ||||||
| Asia‐Pacific | 35 | 2015 [2014 to 2016] | 24 | −2 [−12, 5] | 3 | 3.3 [0.6, 5.6] |
| Caribbean, Central and South America | 13 | 2015 [2013 to 2016] | 16 | 0 [0, 1] | 2 | 10 [3.9, 16.1] |
| Central Africa | 17 | 2016 [2016 to 2016] | 9 | 0 [−1, 16] | 1 | 9.9 [9.9, 9.9] |
| East Africa | 41 | 2016 [2016 to 2017] | 33 | 2 [−1, 7] | 3 | 17.5 [8.7, 19.7] |
| North America | 33 | 2014 [2010 to 2015] | 22 | 11 [−35, 40] | 0 | ‐ |
| Southern Africa | 34 | 2016 [2016 to 2016] | 34 | 2 [1, 2] | 0 | ‐ |
| West Africa | 5 | 2017 [2017 to 2017] | 0 | ‐ | 5 | 6.7 [6.4, 8] |
| Health facility type | ||||||
| Primary (health center) | 92 | 2016 [2016 to 2016] | 79 | 2 [0, 2] | 3 | 6.4 [5.7, 19.7] |
| District hospital | 17 | 2016 [2016 to 2016] | 14 | 2 [−1, 3] | 0 | ‐ |
| Regional/provincial or teaching hospital | 69 | 2015 [2014 to 2016] | 45 | 1 [−9, 12] | 11 | 8 [3.9, 12.7] |
| Sector | ||||||
| Public | 148 | 2016 [2015 to 2016] | 113 | 2 [0, 5] | 13 | 8 [5.6, 12.7] |
| Private | 30 | 2015 [2011 to 2016] | 25 | 0 [−50, 2] | 1 | 6.7 [6.7, 6.7] |
| Facility location | ||||||
| Urban/Mostly urban | 128 | 2016 [2014.5 to 2016] | 91 | 0 [−6, 5] | 13 | 6.7 [5.6, 9.9] |
| Rural/Mostly rural | 50 | 2016 [2016 to 2016] | 47 | 2 [2, 3] | 1 | 19.7 [19.7, 19.7] |
| Country income group | ||||||
| Low income | 54 | 2016 [2016 to 2017] | 49 | 2 [1, 2] | 5 | 12.7 [9.9, 17.5] |
| Lower‐middle income | 42 | 2016 [2016 to 2016] | 31 | 1 [−1, 3] | 5 | 6.4 [5.7, 6.7] |
| Upper‐middle income | 27 | 2016 [2015 to 2016] | 24 | 0 [−3.5, 7] | 1 | 3.9 [3.9, 3.9] |
| High income | 55 | 2015 [2012 to 2015] | 34 | −1 [−21, 27] | 3 | 5.6 [0.6, 16.1] |
| PEPFAR‐supported country | ||||||
| No | 77 | 2015 [2014 to 2016] | 50 | −1 [−13, 21] | 6 | 4.7 [3.3, 12.7] |
| Yes | 101 | 2016 [2016 to 2016] | 88 | 2 [0, 2] | 8 | 8.4 [6.6, 13.7] |
| GFATM‐supported country | ||||||
| No | 66 | 2015 [2013 to 2015] | 44 | −1 [−12.5, 22] | 3 | 5.6 [0.6, 16.1] |
| Yes | 112 | 2016 [2016 to 2016] | 94 | 2 [0, 2] | 11 | 8.0 [5.7, 12.7] |
| Year of national Treat All adoption | ||||||
| 2012 (2 countries) | 33 | 2014 [2010 to 2015] | 22 | 11 [−35, 40] | ‐ | ‐ |
| 2013 (2 countries) | 8 | 2013 [2013 to 2015] | 8 | −0.5 [−9, 18.5] | ‐ | ‐ |
| 2014 (2 countries) | 6 | 2015 [2014 to 2016] | 5 | 12 [0, 12] | ‐ | ‐ |
| 2015 (2 countries) | 16 | 2015 [2014.5 to 2015.5] | 10 | −1 [−7, 5] | ‐ | ‐ |
| 2016 (16 countries) | 95 | 2016 [2016 to 2016] | 89 | 2 [0, 2] | ‐ | ‐ |
| 2017 (2 countries) | 4 | 2013.5 [2011.5 to 2015.5] | 4 | −40.5 [−63, −18] | ‐ | ‐ |
| Timing of national Treat All adoptionb | ||||||
| Before WHO recommendation | 63 | 2015 [2013 to 2015] | 45 | 0 [−9, 22] | ‐ | ‐ |
| After WHO recommendation | 99 | 2016 [2016 to 2016] | 93 | 2 [0, 2] | ‐ | ‐ |
| Treat All not adopted nationally | 16 | 2016.5 [2016 to 2017] | ‐ | ‐ | 14 | 7.4 [5.6, 12.7] |
aSites with known month and year of Treat All introduction; btiming relative to WHO recommendation of September 2015.